Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GBM: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GBM is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, therapeutic target. Associated with AD, ALI, ALS. Connected to 637 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | GBM |
| Full Name | Glioma-Associated Oncogene Homolog |
| Chromosome | 3p25.1 |
| Protein Family | C2H2-type zinc finger transcription factors |
| Exons | 14 |
| Pathways | Amyloid, Angiogenesis, Apoptosis, Autophagy, Blood-Brain Barrier |
| UniProt ID | P08151 |
| NCBI Gene ID | 2735 |
| Ensembl ID | ENSG00000087495 |
| GeneCards | GBM |
| Human Protein Atlas | GBM |
| Chromosomal location | 3p25.1 |
| Exon count | 14 exons |
| Alternative splicing | Produces full-length activator (GLI3A) and truncated repressor (GLI3R) |
| Promoter architecture | Contains GLI-binding sites that enable autoregulation |
| Associated Diseases | AD, Aging, ALI, Als, Alzheimer |
| Known Drugs/Compounds | quercetin, SSRI |
| Interactions | Actin, AIM2, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMPK |
| KG Connections | 1358 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
GBM(["GBM"])
Glioblastoma["Glioblastoma"]
Tumor["Tumor"]
GLIOBLASTOMA(["GLIOBLASTOMA"])
Cancer["Cancer"]
Als["Als"]
CANCER(["CANCER"])
GENES(["GENES"])
GBM -->|"associated with"| Glioblastoma
GBM -->|"activates"| Tumor
GBM -->|"therapeutic target"| Glioblastoma
GBM -->|"associated with"| Tumor
GBM -->|"associated with"| GLIOBLASTOMA
GBM -->|"therapeutic target"| GLIOBLASTOMA
GBM -->|"activates"| Cancer
GBM -->|"associated with"| Cancer
GBM -->|"therapeutic target"| Tumor
GBM -->|"therapeutic target"| Cancer
GBM -->|"regulates"| Als
GBM -->|"activates"| Glioblastoma
GBM -->|"activates"| CANCER
GBM -->|"activates"| GLIOBLASTOMA
GBM -->|"associated with"| GENES
style GBM fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Tumor | activates | disease | 1.00 |
| Glioblastoma | therapeutic_target | disease | 1.00 |
| Glioblastoma | associated_with | disease | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| GLIOBLASTOMA | associated_with | gene | 1.00 |
| GLIOBLASTOMA | therapeutic_target | gene | 1.00 |
| Als | regulates | disease | 0.95 |
| Tumor | therapeutic_target | disease | 0.95 |
| Cancer | associated_with | disease | 0.95 |
| Glioblastoma | activates | disease | 0.95 |
| Cancer | activates | disease | 0.95 |
| Cancer | therapeutic_target | disease | 0.95 |
| glioblastoma | treats | disease | 0.90 |
| T cells | expressed_in | cell_type | 0.90 |
| glioblastoma | targets | disease | 0.90 |
| blood-brain barrier | participates_in | pathway | 0.90 |
| glioblastoma | biomarker_for | disease | 0.90 |
| glioblastoma | associated_with | disease | 0.90 |
| blood-brain barrier | expressed_in | brain_region | 0.90 |
| neural stem cells | regulates | cell_type | 0.90 |
| glioblastoma | regulates | disease | 0.90 |
| oxidative stress response | participates_in | pathway | 0.90 |
| stem cells | expressed_in | cell_type | 0.90 |
| GENES | associated_with | gene | 0.90 |
| GLIOBLASTOMA | activates | gene | 0.90 |
| CANCER | activates | gene | 0.90 |
| CANCER | associated_with | gene | 0.90 |
| Glioblastoma | regulates | disease | 0.85 |
| Glioma | activates | disease | 0.85 |
| Glioma | therapeutic_target | disease | 0.85 |
| Glioblastoma | expressed_in | disease | 0.85 |
| Aging | therapeutic_target | disease | 0.85 |
| Als | activates | disease | 0.85 |
| neural stem cells | activates | cell_type | 0.80 |
| MS4A6A | activates | gene | 0.80 |
| unfolded protein response | participates_in | pathway | 0.80 |
| glioblastoma | interacts_with | disease | 0.80 |
| macrophages | inhibits | cell_type | 0.80 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.80 |
| lipid metabolism | participates_in | pathway | 0.80 |
| immunosuppression | associated_with | pathway | 0.80 |
| neural stem cells | associated_with | cell_type | 0.80 |
| microglia | inhibits | cell_type | 0.80 |
| GENES | activates | gene | 0.80 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.80 |
| AKT | activates | gene | 0.80 |
| Invasion | associated_with | pathway | 0.80 |
| CANCER | therapeutic_target | gene | 0.80 |
| GLIOBLASTOMA | expressed_in | gene | 0.80 |
| Tumor | biomarker_for | disease | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| EGFR | activates | gene | 0.90 |
| PI3K | activates | gene | 0.80 |
| Wnt | associated_with | pathway | 0.70 |
| PI3K/AKT/MTOR | regulates | pathway | 0.70 |
| PI3K | therapeutic_target | gene | 0.70 |
| TGF-β | associated_with | pathway | 0.70 |
| EGFR | associated_with | gene | 0.70 |
| ERK | activates | gene | 0.70 |
| DNA | therapeutic_target | gene | 0.70 |
| STAT3 | therapeutic_target | gene | 0.70 |
| PTEN | activates | gene | 0.70 |
| TP53 | associated_with | gene | 0.70 |
| CDKN2A | associated_with | gene | 0.70 |
| FN1 | regulates | gene | 0.70 |
| PTEN | associated_with | gene | 0.70 |
| SORLA | expressed_in | gene | 0.60 |
| CPLX3 | inhibits | gene | 0.60 |
| ASTROCYTE | contributes_to | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| TNF | associated_with | gene | 0.60 |
| CAV1 | biomarker_for | gene | 0.60 |
| CPLX3 | activates | gene | 0.60 |
| CD68 | biomarker_for | gene | 0.60 |
| CD44 | regulates | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| CD8 | expressed_in | gene | 0.60 |
| ANXA1 | implicated_in | gene | 0.60 |
| C3 | associated_with | gene | 0.60 |
| TMEM119 | expressed_in | gene | 0.60 |
| C3 | expressed_in | gene | 0.60 |
| ASTROCYTES | associated_with | gene | 0.60 |
| FLOT1 | activates | gene | 0.60 |
| GAP43 | interacts_with | gene | 0.60 |
| ANXA1 | causes | gene | 0.60 |
| CLDN3 | activates | gene | 0.60 |
| AIM2 | activates | gene | 0.60 |
| CXCR4 | activates | gene | 0.60 |
| APC | activates | gene | 0.60 |
| ASCL1 | regulates | gene | 0.60 |
| OMA1 | activates | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| AKT | disrupts | gene | 0.60 |
| CRY | activates | gene | 0.60 |
| MICRORNAS | therapeutic_target | gene | 0.60 |
| ERK | associated_with | gene | 0.60 |
| MICROGLIA | inhibits | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| POSTN | inhibits | gene | 0.60 |
| MICROGLIA | associated_with | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GBM in their description or question text
No additional research found